TAGline November 2024
This year’s edition of TAGline takes stock of the state of the HIV, TB, and HCV pandemics worldwide, and advances bold visions for what a future without them must look like.
1/4/6×24 Campaign Concerned Prices Hinder Uptake of Important Updated World Health Organization Drug-Resistant TB Treatment Recommendations
The 1/4/6x24 Campaign warns that regimens to treat drug-resistant TB recently recommended by World Health Organization (WHO) and important diagnostic tools will remain out of reach due to high prices.
Policy Approaches to Seemingly Intractable Challenges: Global and Domestic Activism in a Time of Divided Government
By Lizzy Lovinger and Mark Harrington This November’s U.S. election provides an opportunity for activists to pause and assess our approach to policy. We face some unprecedented roadblocks on our path to end HIV, hepatitis C virus (HCV), and tuberculosis…
A New Pandemic Agreement Cannot Succeed If It Ignores Human Rights
By Mike Frick and Gisa Dang Background Two years into the COVID-19 pandemic, governments embarked on a journey to create a Pandemic Agreement, negotiated among member states of the World Health Organization (WHO), that would establish binding rules on how…
Accessible DAAs Shouldn’t Be DOA: Delivering on the Promise of Negotiated Price Reductions for HCV Treatment
By Joelle Dountio Ofimboudem The hepatitis C Virus (HCV) remains one of the deadliest infectious diseases, despite the existence of an effective eight- to-twelve week cure. Still, of the 50 million people estimated to be living with HCV worldwide, 36…
Breaking Barriers: Ensuring Access to Disability-Inclusive TB and HIV Services
By Wilson Kutamba and Richard Musisi With an estimated TB incidence of 200 cases per 100,000, Uganda is one of the 30 countries with the highest burden of TB/HIV globally. For the estimated 86,000 people living here who fell ill…
From Property to Power: Confronting the Historic Roots of Black Women’s Health Disparities
By De'Ashia Lee Among women aged 24–35, Black women were the only U.S. demographic for which HIV disease was a leading cause of death in 2021. 1 This alarming health disparity is the end result of a culture of oppression and…
2024 TAG Update
As we approach the end of 2024, we want to share with you some of the remarkable progress we’ve made together, and you'll see some of our work in the 2024 TAG Update.
Finally, Children of All Ages Can Benefit from 3HP to Prevent TB!
The Community Research Advisors Group (CRAG) celebrates both the findings and the methodology of Study 35, a phase I/II clinical trial of the tuberculosis (TB) preventive treatment regimen known as 3HP in children.
TAG Statement on the Global Fund and Other Funding Sources to Fight TB, HIV, and Other Pandemics
In advance of the 52nd Meeting of the Board of the Global Fund to Fight AIDS, Tuberculosis, and Malaria (the Global Fund) and the 2024 Union World Conference on Lung Health, Treatment Action Group (TAG) releases this statement in response to ongoing conversations about the Global Fund’s program allocations for HIV, tuberculosis (TB), and malaria.